CARDIOVASCULAR INNOVATIONS 2022: The Operators EnclaveTM

JULY 21-23, 2022

HYATT REGENCY DENVER AT COLORADO CONVENTION CENTER

Cardiovascular Innovations 2022: The Operators EnclaveTM is a world-class meeting focused on state-of-the-art therapy for peripheral, coronary, and structural heart disease. The conference features:

• Highly interactive expert discussions focused on professional experiences
• An emphasis on the latest innovations in interventional cardiovascular care
• Live case transmissions by the world's leading operators in the United States and Europe
• Satellite symposia and hands-on workshops

TARGET AUDIENCE

Cardiovascular Innovations 2022: The Operators EnclaveTM is designed to meet the needs of cardiologists, surgeons, internists, trainees, investigators, nurses, nurse practitioners, physician assistants and allied health care staff who participate in the care of patients with coronary, peripheral, and structural cardiovascular diseases. The focus of the conference is on innovative health care solutions for these patients.

ABOUT CARDIOVASCULAR INNOVATIONS FOUNDATION

Cardiovascular disease is the number one cause of death globally, accounting for nearly 17.5 million deaths each year. Cardiovascular disease may strike those in their prime years and, due to population aging, also afflict elderly people who are otherwise living healthy lives. Improvements in cardiovascular therapy have markedly reduced procedural risk, and thereby enabled the treatment of a broad range of patients, more than ever before in the history of medicine. Nonetheless, significant disparities in the delivery of cardiovascular care continue to exist, leading to large unmet clinical needs for many patients worldwide. Innovation in the delivery of cardiovascular care, as well as education of the public at-large, is essential for optimizing the management of these patients.

The Cardiovascular Innovations Foundation is organized and operated exclusively for charitable, scientific, and educational purposes within the meaning of Section 501(c)(3) of the Internal Revenue Code.

The mission of the Foundation is to address unmet needs in cardiovascular care through the study, design, and development of innovative health care solutions and education of health care providers and the larger public.

BOARD OF DIRECTORS

Subhash Banerjee, MD, FACC, FSCAI

Professor of Medicine, University of Texas Southwestern Medical Center

Chief, Division of Cardiology Director, Cardiac Catheterization Laboratory

VA North Texas Health Care System

Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FSCAI, FESC

Director, Center for Complex Coronary Interventions

Minneapolis Heart Institute at Abbott Northwestern Hospital

Mehdi H. Shishehbor, DO, MPH, PhD, FACC, FAHA, FSCAI

Professor of Medicine, CWRU

Chair, Harrington Heart & Vascular Institute

Director, Cardiovascular Interventional Center

Co-Director, Vascular Center

University Hospitals of Cleveland

Paul Sorajja, MD, FACC, FAHA, FSCAI

Director, Center for Valve and Structural Heart Disease

Minneapolis Heart Institute at Abbott Northwestern Hospital

Director, Valve Science Center

Minneapolis Heart Institute Foundation